Researchers from The Ohio State University Wexner Medical Center and College of Medicine's School of Health and Rehabilitation Sciences (HRS) recently published a study that found a link between ...
Many with Crohn’s disease or ulcerative colitis sacrifice essential purchases like food and clothing for healthcare, survey ...
("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, ...
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and ...
Jon Imondi, 43, from Worcester, was diagnosed with stage three bowel cancer in December 2022 after dismissing the symptoms as ...
Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...